Tavares Clint D J, Sharabi Kfir, Dominy John E, Lee Yoonjin, Isasa Marta, Orozco Jose M, Jedrychowski Mark P, Kamenecka Theodore M, Griffin Patrick R, Gygi Steven P, Puigserver Pere
From the Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 and.
Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 and.
J Biol Chem. 2016 May 13;291(20):10635-45. doi: 10.1074/jbc.M115.706200. Epub 2016 Mar 28.
Methionine is an essential sulfur amino acid that is engaged in key cellular functions such as protein synthesis and is a precursor for critical metabolites involved in maintaining cellular homeostasis. In mammals, in response to nutrient conditions, the liver plays a significant role in regulating methionine concentrations by altering its flux through the transmethylation, transsulfuration, and transamination metabolic pathways. A comprehensive understanding of how hepatic methionine metabolism intersects with other regulatory nutrient signaling and transcriptional events is, however, lacking. Here, we show that methionine and derived-sulfur metabolites in the transamination pathway activate the GCN5 acetyltransferase promoting acetylation of the transcriptional coactivator PGC-1α to control hepatic gluconeogenesis. Methionine was the only essential amino acid that rapidly induced PGC-1α acetylation through activating the GCN5 acetyltransferase. Experiments employing metabolic pathway intermediates revealed that methionine transamination, and not the transmethylation or transsulfuration pathways, contributed to methionine-induced PGC-1α acetylation. Moreover, aminooxyacetic acid, a transaminase inhibitor, was able to potently suppress PGC-1α acetylation stimulated by methionine, which was accompanied by predicted alterations in PGC-1α-mediated gluconeogenic gene expression and glucose production in primary murine hepatocytes. Methionine administration in mice likewise induced hepatic PGC-1α acetylation, suppressed the gluconeogenic gene program, and lowered glycemia, indicating that a similar phenomenon occurs in vivo These results highlight a communication between methionine metabolism and PGC-1α-mediated hepatic gluconeogenesis, suggesting that influencing methionine metabolic flux has the potential to be therapeutically exploited for diabetes treatment.
蛋氨酸是一种必需的含硫氨基酸,参与蛋白质合成等关键细胞功能,并且是维持细胞内稳态所涉及的关键代谢物的前体。在哺乳动物中,肝脏会根据营养状况,通过改变蛋氨酸在转甲基、转硫和转氨代谢途径中的通量,在调节蛋氨酸浓度方面发挥重要作用。然而,目前尚缺乏对肝脏蛋氨酸代谢如何与其他调节性营养信号和转录事件相互作用的全面了解。在此,我们表明转氨途径中的蛋氨酸及其衍生的含硫代谢物会激活GCN5乙酰转移酶,促进转录共激活因子PGC-1α的乙酰化,从而控制肝脏糖异生。蛋氨酸是唯一能通过激活GCN5乙酰转移酶快速诱导PGC-1α乙酰化的必需氨基酸。利用代谢途径中间体进行的实验表明,蛋氨酸转氨作用而非转甲基或转硫途径,促成了蛋氨酸诱导的PGC-1α乙酰化。此外,转氨酶抑制剂氨基氧乙酸能够有效抑制蛋氨酸刺激的PGC-1α乙酰化,这伴随着原代小鼠肝细胞中PGC-1α介导的糖异生基因表达和葡萄糖生成的预期变化。给小鼠注射蛋氨酸同样会诱导肝脏PGC-1α乙酰化,抑制糖异生基因程序,并降低血糖,表明类似现象在体内也会发生。这些结果突显了蛋氨酸代谢与PGC-1α介导的肝脏糖异生之间的联系,提示影响蛋氨酸代谢通量可能具有治疗糖尿病的潜在用途。